Article
CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations.
PloS one - 1 Jan 2012
Fogli Anne, Merle Christine, Roussel Véronique, Schiffmann Raphael, Ughetto Sylvie, Theisen Manfred, Boespflug-Tanguy Odile
Abstract excerpt
BACKGROUND: Primary or secondary abnormalities of glycosylation have been reported in various brain diseases. Decreased asialotransferrin to sialotransferrin ratio in cerebrospinal fluid (CSF) is a diagnostic marker of leukodystrophies related to mutations of genes encoding translation initiation factor, EIF2B. We investigated the CSF glycome of eIF2B-mutated patients and age-matched normal individuals in order...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
